fig1
Figure 1. Hypothesis-driven framework for a pilot longitudinal microbiome and biomarker study in GD. GD: Gaucher disease; GBA1: glucosylceramidase beta 1; ERT: enzyme replacement therapy; 16S rRNA: 16S ribosomal RNA. Created in BioRender. Sharma, R.R. (2026) https://BioRender.com/w94arl2 Created using BioRender: .
